title: Imatinib for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
authors.affiliation: Department of Respiratory Medicine, Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine, Ishikawa, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Watanabe
authors.affiliation: Department of Respiratory Medicine, Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine, Ishikawa, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Waseda
authors.affiliation: Department of Respiratory Medicine, Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine, Ishikawa, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kimura
authors.affiliation: Department of Respiratory Medicine, Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine, Ishikawa, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Takato
authors.affiliation: Department of Hematology, Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine, Ishikawa, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Ohata
authors.affiliation: Department of Hematology, Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine, Ishikawa, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kondo
authors.affiliation: Department of Respiratory Medicine, Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine, Ishikawa, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Kasahara
authors.affiliation: Department of Hematology, Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine, Ishikawa, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Nakao
mesh_terms: D000328:Adult; D064591:Allografts; D001989:Bronchiolitis Obliterans / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000068877:Imatinib Mesylate / Q000008:administration & dosage*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D000068877:Imatinib Mesylate